Search results for: Oncology
Filter search results
OHE Appoints New Deputy Director: Associate Professor Paula Lorgelly
13 August 2015
…research spans three key areas of health economics: the determinants of health, economic evaluation and outcome measurement. She is currently working in the clinical areas of oncology, including genomic testing;…
Do Respondents Completing Abstract, Hypothetical Priority-Setting Exercises Agree with the Policy Implications of Their Choices?
3 March 2015
…Oncology Initiative, examined the impact of alternative presentations of hypothetical priority setting scenarios, and the extent to which the study respondents agreed with the policy implications of their responses to…
The Dynamics of Drug Shortages
9 January 2024
…Oncology, 24, pp.v17–v22. 10.1093/annonc/mdt324. Eversana, 2022. English Pharmacies Making a Loss When Dispensing Strep A Antibiotics, Amid Surge in Infections. Navlin Daily. Available at: https://www.navlindaily.com/article/15115/english-pharmacies-making-a-loss-when-dispensing-strep-a-antibiotics-amid-surge-in-infections [Accessed 7 Jun. 2023]. Francois, C., Gawlik,…
OHE at ISPOR Europe 2: Conceptual and Practical Challenges in Judging Value
29 October 2014
…decision making. For OHE’s primer on MCDA, click here. 3. The Expanding Value Footprint of Oncology Treatments. Juan Carlos Rejon-Parrilla (OHE), Karla Herandez-Villafuerte (OHE), Koonal K Shah (OHE), Jorge Mestre-Ferrandiz…
Defining Innovation in Medicines and Transforming it into Value
3 July 2013
…here, and on Shah, K.K., Mestre-Ferrandiz, J., Towse, A. and Smythe, E.N. (2013) A review of health technology appraisals: case studies in oncology. International Journal of Technology Assessment in Health Care. 29(1),…
A Framework for Value-aligned Pricing of Combination Therapies
25 June 2024
…development of combination therapies becoming more common in oncology and beyond, and a lack of agreed-upon pricing models in Europe, the need for innovative pricing strategies is increasingly evident. The…
Review of Plans for Refining Patient-Reported Outcomes Measures
19 February 2013
…the EuroQol Group’s scientific research agenda for the coming year and plans for the EQ-5D-5L approach to measuring patient-reported outcomes of care. Health technology assessment affects patients’ access to oncology…
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
…600% from the 1970s[3] to the 2000s[4]. Second, success rates for clinical development are falling as tougher therapeutic areas are tackled—e.g. neurology (Alzheimer’s), autoimmune diseases (arthritis), and oncology. Success rates…
Chittawan Poonsiri
4 September 2024
…University, Thailand. After graduation, she served as a hospital pharmacist, specializing in oncology patient care. Currently, she is a Senior Associate at the Health Intervention and Technology Assessment Program (HITAP)….